These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6760696)

  • 1. Production of macrophage activating factor by cytolytic and noncytolytic T lymphocyte clones.
    Kelso A; Glasebrook AL; Brunner KT; Kanagawa O; Engers HD; MacDonald HR; Cerottini JC
    Adv Exp Med Biol; 1982; 155():493-8. PubMed ID: 6760696
    [No Abstract]   [Full Text] [Related]  

  • 2. Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones.
    Kelso A; Glasebrook AL
    J Immunol; 1984 Jun; 132(6):2924-31. PubMed ID: 6202766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
    Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
    J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of both macrophage activating and inhibiting activities by a murine T-lymphocyte hybridoma.
    Jones CM; Braatz JA; Herberman RB
    Nature; 1981 Jun; 291(5815):502-3. PubMed ID: 7015153
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of a T cell hybridoma which produces extraordinary quantities of macrophage activating factor.
    Schreiber RD; Altman A; Katz DH
    Adv Exp Med Biol; 1982; 155():499-506. PubMed ID: 6760697
    [No Abstract]   [Full Text] [Related]  

  • 6. Lysis of inducer T cell clones by activated macrophages and macrophage-like cell lines.
    Rao A; Faas SJ; Miller LJ; Riback PS; Cantor H
    J Exp Med; 1983 Oct; 158(4):1243-58. PubMed ID: 6194244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones.
    Kelso A; Munck A
    J Immunol; 1984 Aug; 133(2):784-91. PubMed ID: 6203981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous T-cell lymphokine production and enhanced macrophage Ia expression and tumoricidal activity in MRL-lpr mice.
    Lu CY; Unanue ER
    Clin Immunol Immunopathol; 1982 Nov; 25(2):213-22. PubMed ID: 6762274
    [No Abstract]   [Full Text] [Related]  

  • 9. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.
    Kelso A; MacDonald HR; Smith KA; Cerottini JC; Brunner KT
    J Immunol; 1984 Jun; 132(6):2932-8. PubMed ID: 6233365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-independent activation of helper T cells. I. Production of Interleukin 2.
    Farrar JJ; Mizel SB; Fuller-Farrar J; Farrar WL; Hilfiker ML
    J Immunol; 1980 Aug; 125(2):793-8. PubMed ID: 6967089
    [No Abstract]   [Full Text] [Related]  

  • 11. Heterogeneity of lymphokine production by murine T-lymphocyte clones.
    MacDonald HR; Glasebrook AL; Kelso A; Zubler RH
    Ann Immunol (Paris); 1982; 133D(2):171-8. PubMed ID: 6819809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytolytic T lymphocyte clones.
    MacDonald HR; Sekaly RP; Kanagawa O; Thiernesse N; Taswell C; Cerottini JC; Weiss A; Glasebrook AL; Engers HD; Kelso A; Brunner KT; Bron C
    Immunobiology; 1982 Mar; 161(1-2):84-106. PubMed ID: 6284635
    [No Abstract]   [Full Text] [Related]  

  • 13. D-Mannose as a component of the macrophage surface receptor for macrophage-activating factor(MAF) in mice.
    Yamamoto S; Tokunaga T
    Cell Immunol; 1981 Jul; 61(2):319-31. PubMed ID: 7018700
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of gamma-interferon as a murine macrophage-activating factor for tumor cytotoxicity.
    Schreiber RD
    Contemp Top Immunobiol; 1984; 13():171-98. PubMed ID: 6428805
    [No Abstract]   [Full Text] [Related]  

  • 15. Macrophage-activating factor for cytotoxicity produced by a human T-cell hybridoma.
    Higuchi M; Nakamura N; Tsuchiya SI; Kobayashi Y; Osawa T
    Cell Immunol; 1984 Sep; 87(2):626-36. PubMed ID: 6205774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of Leishmania donovani antigens by murine T lymphocyte lines and clones. Species cross-reactivity, functional correlates of cell-mediated immunity, and antigen characterization.
    Sheppard HW; Scott PA; Dwyer DM
    J Immunol; 1983 Sep; 131(3):1496-503. PubMed ID: 6193191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma.
    Margolick JB; Ambrus JL; Volkman DJ; Fauci AS
    J Immunol; 1986 Jan; 136(2):546-54. PubMed ID: 2416812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in direct cytotoxic function of L3T4 T cells. TH1 clones express higher cytotoxic activity to antigen-presenting cells than TH2 clones.
    Chang JC; Zhang L; Edgerton TL; Kaplan AM
    J Immunol; 1990 Jul; 145(2):409-16. PubMed ID: 1973181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactive cloned T cell lines. IV. Interaction of alloantigen and T cell growth factors (TCGF) to stimulate cloned cytolytic T lymphocytes.
    Lutz CT; Glasebrook AL; Fitch FW
    J Immunol; 1981 Jul; 127(1):391-2. PubMed ID: 6453898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.